Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study (Q46585156)
Jump to navigation
Jump to search
scientific article published on 5 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study |
scientific article published on 5 July 2005 |
Statements
1 reference
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study (English)
1 reference
1 reference
Evanthia Galanis
1 reference
Bernd W Scheithauer
1 reference
Jan C Buckner
1 reference
Matthew J Maurer
1 reference
Jeffrey I Kreisberg
1 reference
Karla Ballman
1 reference
J Boni
1 reference
Josep M Peralba
1 reference
Robert B Jenkins
1 reference
Shaker R Dakhil
1 reference
Roscoe F Morton
1 reference
Kurt A Jaeckle
1 reference
Janet Dancey
1 reference
Daniel J Walsh
1 reference
North Central Cancer Treatment Group
1 reference
5 July 2005
1 reference
1 reference
23
1 reference
5294-5304
1 reference
23
1 reference
Identifiers
1 reference
1 reference